Logo-jcvtr

J Cardiovasc Thorac Res. 2020;12(1): 20-26. doi: 10.34172/jcvtr.2020.04
PMID: 32211134        PMCID: PMC7080335

Original Article

Agreement between Framingham, IraPEN and non-laboratory WHO-EMR risk score calculators for cardiovascular risk prediction in a large Iranian population

Mohsen Mirzaei 1 ORCID, Masoud Mirzaei 1 * ORCID

Cited by CrossRef: 3


1- Hasandokht T, Maroufizadeh S, Joukar F, Salari A, Mansour-Ghanaei F. Ten-Year Cardiovascular Disease Risk Evaluation in PERSIAN Guilan Cohort Study: A Cross-Sectional Study. J Occup Health Epidemiol. 2023;12(2):78 [Crossref]
2- Rezaei F, Seif M, Gandomkar A, Fattahi M, Hasanzadeh J. Agreement between laboratory-based and non-laboratory-based Framingham risk score in Southern Iran. Sci Rep. 2021;11(1) [Crossref]
3- Dehghan A, Ahmadnia Motlagh S, Khezri R, Rezaei F, Aune D. A comparison of laboratory-based and office-based Framingham risk scores to predict 10-year risk of cardiovascular diseases: a population-based study. J Transl Med. 2023;21(1) [Crossref]
4- Saki N, Babaahmadi-Rezaei H, Rahimi Z, Raeisizadeh M, Jorfi F, Seif F, Cheraghian B, Ghaderi-Zefrehi H, Rezaei M. Impact of modifiable risk factors on prediction of 10-year cardiovascular disease utilizing framingham risk score in Southwest Iran. BMC Cardiovasc Disord. 2023;23(1) [Crossref]
5- Yang X, Huang K, Yang D, Zhao W, Zhou X. Biomedical Big Data Technologies, Applications, and Challenges for Precision Medicine: A Review. Global Challenges. 2024;8(1) [Crossref]
6- Agyekum F, Akumiah F, Nguah S, Appiah L, Ganatra K, Adu-Boakye Y, Folson A, Ayetey H, Owusu I. Atherosclerotic cardiovascular disease risk among Ghanaians: A comparison of the risk assessment tools.. American Journal of Preventive Cardiology. 2024;18:100670 [Crossref]
7- Faramarzi E, Somi M, Ostadrahimi A, Molani-Gol R, Khamnian Z, Ghaffari S, Amiri B. Risk estimation of cardiovascular diseases using the World Health Organization/International Society of Hypertension risk prediction charts in the Azar cohort population: Cross-sectional study. J Cardiovasc Thorac Res. 2024;16(2):88 [Crossref]
8- Thagizadeh A, Ghahramanian A, Zamanzadeh V, Aslanabadi N, Onyeka T, Ramazanzadeh N. Illness perception and cardiovascular risk factors in patients with myocardial infarction undergoing percutaneous coronary intervention in Iran. BMC Cardiovasc Disord. 2022;22(1) [Crossref]
9- Momayyezi M, Sefidkar R, Fallahzadeh H. Agreement between ten-years cardiovascular disease risk assessment tools: An application to Iranian population in Shahedieh Cohort Study. Heliyon. 2023;9(10):e20396 [Crossref]